Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$144.95 - $152.29 $25.3 Million - $26.5 Million
174,300 Added 2526.09%
181,200 $27.4 Million
Q2 2022

Aug 08, 2022

BUY
$83.14 - $145.99 $557,038 - $978,133
6,700 Added 3350.0%
6,900 $1.01 Million
Q2 2021

Aug 16, 2021

BUY
$65.78 - $105.02 $6,578 - $10,502
100 Added 100.0%
200 $19,000
Q2 2019

Aug 14, 2019

SELL
$39.79 - $67.01 $632,661 - $1.07 Million
-15,900 Reduced 99.38%
100 $4,000
Q1 2019

May 15, 2019

SELL
$34.52 - $53.29 $1.04 Million - $1.6 Million
-30,000 Reduced 65.22%
16,000 $824,000
Q4 2018

Feb 14, 2019

BUY
$29.75 - $42.9 $1.37 Million - $1.97 Million
46,000 New
46,000 $1.7 Million

Others Institutions Holding BHVN

About Biohaven Pharmaceutical Holding Co Ltd.


  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.65B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.